See All Slides - tctmd.com

Slides

Presentation TCT 2012

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

Presenter: Vivek Reddy

October 23, 2012

Presentation TCT 2012

TCT-36. Circumferential Distribution of the Neointima Tissue at 6 Months and 2 at Years Follow-up After a Bioresorbable Scaffold Implantation: A Serial Optical Coherence...

Presenter: Christos Bourantas

October 23, 2012

Presentation TCT 2012

ELM Presentation(10)

Presenter: Thomas Tu

October 23, 2012

Presentation TCT 2012

TCT-85. Efficacy and Safety of Percutaneous Patent Foramen Ovale Closure in Patients with a Hypercoagulable Disorder

Presenter: Ignacio Cruz-Gonz?lez

October 23, 2012

Presentation TCT 2012

State-of-the-Field Keynote: Future Perspectives in the Device-Based Treatment for Heart Failure

Presenter: Daniel Burkhoff

October 23, 2012

Presentation TCT 2012

Radial Approach Offers No Benefit Over Femoral Plus Bivalirudin!

Presenter: James Hermiller Jr

October 23, 2012

Presentation TCT 2012

Stem Cell Therapies: State of the Art (Including the FOCUS Trial)

Presenter: Robert Simari

October 23, 2012

Presentation TCT 2012

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress

Presenter: Timothy Henry

October 23, 2012

Presentation TCT 2012

Cardia LAA Closure Device: Description and Preclinical Results

Presenter: Juan Granada

October 23, 2012

Presentation TCT 2012

TCT-97. Three-dimensional Echocardiographic Measurements of the Aortic Annulus Predict Paravavular Regurgitation Following Transcatheter Aortic Valve Replacement

Presenter: Rebecca Hahn

October 23, 2012

Advertisement

Slides

The New Fourth-Generation WATCHMAN (BSC-Atritech): Device Design and Results of the EVOLVE Trial

TCT-36. Circumferential Distribution of the Neointima Tissue at 6 Months and 2 at Years Follow-up After a Bioresorbable Scaffold Implantation: A Serial Optical Coherence...

ELM Presentation(10)

TCT-85. Efficacy and Safety of Percutaneous Patent Foramen Ovale Closure in Patients with a Hypercoagulable Disorder

State-of-the-Field Keynote: Future Perspectives in the Device-Based Treatment for Heart Failure

Radial Approach Offers No Benefit Over Femoral Plus Bivalirudin!

Stem Cell Therapies: State of the Art (Including the FOCUS Trial)

Overview 1: Biological Therapies for Heart Failure: Clinical Perspectives and Progress

Cardia LAA Closure Device: Description and Preclinical Results

TCT-97. Three-dimensional Echocardiographic Measurements of the Aortic Annulus Predict Paravavular Regurgitation Following Transcatheter Aortic Valve Replacement

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content